medigraphic.com
Instituto Nacional de Salud Pública

2016, Number 2

<< Back Next >>

salud publica mex 2016; 58 (2)

The burden of disease of cancer in the Mexican Social Security Institute

González-León M, Fernández-Gárate JE, Rascón-Pacheco RA, Valladares-Aranda MÁ, Dávila-Torres J, Borja-Aburto VH

Language: English
References: 22
Page: 132-141
PDF size: 753.55 Kb.


ABSTRACT

Objective. To estimate the disease burden of cancer in the affiliate population of the Mexican Social Security Institute (Instituto Mexicano del Seguro Social, IMSS) in 2010 by delegation. Materials and methods. The Disability-Adjusted Life Years (DALYs), Years of Life Lost (YLL) due to premature mortality and Years Lived with Disability/Disease (YLD) for 21 specific cancers and a subgroup of other malignant neoplasms were calculated based on the methodology of the Global Burden of Disease Study (GBD) for each of the 35 delegations of the IMSS. Results. In 2010, cancer represented the fifth overall leading cause of disease burden in IMSS affiliates (16.72 DALYs/1000 affiliates). A total of 75% of the cancer disease burden in each delegation is due to ten specific cancers, particularly breast cancer, which ranks first in 82% of the delegations. Prostate cancer; tracheal, bronchial, and lung cancers; leukemia, and colorectal and stomach cancers occupy the second to fourth positions in each delegation. With the exception of breast and prostate cancer, for which the contribution of YLD to the DALYs was higher than 50%, the greatest contribution to the DALYs of the other cancers was premature mortality, which accounted for more than 90% of the DALYs in some cases. Conclusion. The results obtained in this study allow for the identification of intervention priorities with regard to cancer at the institutional level and also for the focus at the delegation level to be placed on cancers ranking in the top positions for disease burden.


REFERENCES

  1. 1.GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385(9963):117-71. doi: http:// dx.doi.org/10.1016/S0140-6736(14)61682-2

  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359-E386. doi: 10.1002/ijc.29210.

  3. Mathers CD, Stevens GA, Boerma T, White RA, Tobias MI. Causes of international increases in older age life expectancy. The Lancet 385(9967):540-548. doi: http://dx.doi.org/10.1016/S0140-6736(14)60569-9.

  4. Cleries R, Martínez JM, Valls J, Pareja L, Esteban L, Gispert R, et al. Life expectancy and age–period–cohort effects: analysis and projections of mortality in Spain between 1977 and 2016. Public Health 2009;123(2):156- 162. doi: http://dx.doi.org/10.1016/j.puhe.2008.10.026.

  5. Martinez-Beneyto V, Brugulat-Guiteras P, Mompart-Penina A, Rosas-Ruiz A, Tresserras-Gaju R. Impacto de los trastornos crónicos en la esperanza de vida de la población de Cataluña en 1994 y 2006. Medicina clinica 2011;137 Suppl 2:9-15. doi: 10.1016/s0025-7753(11)70022-7.

  6. Secretaría de Salud SdPyPdlS. Los cinco tipos de cáncer que más afectan a mexicanos [accessed August 21, 2015]. Disponible en: http:// wwwsppssaludgobmx/noticias/1445-5-tipos-cancer-mas-afectan-mexicanoshtml. 2013.

  7. Secretaría de Gobernación, Consejo Nacional de Población (Conapo) [Sitio de internet]. México en cifras: Proyecciones de la Población 2010- 2050. México, 2015 [accessed August 20, 2015]. Available at: http://www. conapo.gob.mx/es/CONAPO/Proyecciones

  8. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. European Journal of Cancer 2009;45(6):1042-1066. doi: http:// dx.doi.org/10.1016/j.ejca.2008.11.029.

  9. Kawabata-Shoda E, Charvat H, Ikeda A, Inoue M, Sawada N, Iwasaki M, et al. Trends in cancer prognosis in a population-based cohort survey: Can recent advances in cancer therapy affect the prognosis? Cancer Epidemiology 2015;39(1):97-103. doi: http://dx.doi.org/10.1016/j. canep.2014.11.008.

  10. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M. National Burden of Disease Studies: A Practical Guide. Global Program on Evidence for Health Policy. 2001. Geneva: World Health Organization, 2001.

  11. Instituto Nacional de Estadística y Geografía (Inegi) [Sitio de internet]. Registros Administrativos: Mortalidad [accessed August 20, 2015]. Available at: http://www.inegi.org.mx/est/contenidos/proyectos/registros/

  12. Social. IMdS. Memoria Estadística IMSS 2011. Disponible en: http://wwwimssgobmx/ conoce-al-imss/memoria-estadistica-2011. 2011.

  13. Geografia INdEy. Censo de Población y Vivienda 2010. Disponible en: http://wwwinegiorgmx/est/lista_cubos/consultaaspx?p=pob&c=1. 2010.

  14. Aguirre A, Vela Peón F. La mortalidad infantil en México, 2010. Papeles de Población [en línea] 2012;18(73):1-15 [accessed August 20, 2015] Available at: http://agricola-www.redalyc.org/articulo.oa?id=11224638003 ISSN 1405-7425

  15. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2129-2143. doi: 10.1016/S0140- 6736(12)61680-8.

  16. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994;72(3):429-445.

  17. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2197-2223. doi: 10.1016/S0140- 6736(12)61689-4.

  18. Anderson WF, Camargo MC, Fraumeni JF, Correa P, Rosenberg PS, Rabkin CS. Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults. JAMA 2010;303(17):1723-1728. doi: 10.1001/jama.2010.496.

  19. Ministerio de Salud. Dirección General de Epidemiología. Análisis de la situación del cáncer en Perú. Lima, Perú: Ministerio de Salud, 2013 [accessed August 20, 2015]. Available at: http://www.dge.gob.pe/portal/ docs/asis_cancer.pdf

  20. Esquiaqui-Felipe R, Posso-Valencia H, Penaloza RE, Rodriguez-Garcia J. Carga de enfermedad por cancer en Santander, Colombia, 2005. Rev Salud Publica 2012;14(2):213-225.

  21. Lozano R, Gomez-Dantes H, Garrido-Latorre F, Jimenez-Corona A, Campuzano-Rincon JC, Franco-Marina F, et al. La carga de enfermedad, lesiones, factores de riesgo y desafios para el sistema de salud en Mexico. Salud Publica Mex 2013;55(6):580-594.

  22. Lozano R, Gómez-Dantés H, Pelcastre B, Ruelas MG, Montañez JC, Campuzano JC, et al. Carga de la enfermedad en México, 1990-2010. Nuevos resultados y desafíos. Cuernavaca, México: Instituto Nacional de Salud Pública / Secretaría de Salud, 2014 [accessed August 20, 2015]. Available at: http://cnegsr.salud.gob.mx/contenidos/descargas/EquidadGenero/Libros/ cargaEnfermedad.pdf




2020     |     www.medigraphic.com